SFI
VNDA icon

Susquehanna Fundamental Investments’s Vanda Pharmaceuticals VNDA Stock Holding History

Susquehanna Fundamental Investments’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-15,137
Closed -$134K – 692
2025
Q4 		$134K Hold
15,137
– – ﹤0.01% 527
2025
Q3 		$75.5K Sell
15,137
-8,578
-36% -$39.7K ﹤0.01% 541
2025
Q2 		$112K Sell
23,715
-111,429
-82% -$487K ﹤0.01% 692
2025
Q1 		$620K Sell
135,144
-119,701
-47% -$558K 0.01% 796
2024
Q4 		$1.22M Buy
+254,845
New +$1.22M 0.02% 647
2024
Q2 		$1.63M Buy
287,677
+5,994
+2% +$31K 0.04% 454
2024
Q1 		$1.16M Buy
+281,683
New +$1.13M 0.05% 322
2022
Q1 		– Sell
-36,780
Closed -$577K – 1703
2021
Q4 		$577K Sell
36,780
-12,620
-26% -$220K 0.02% 856
2021
Q3 		$847K Sell
49,400
-7,795
-14% -$137K 0.02% 941
2021
Q2 		$1.23M Buy
57,195
+1,928
+3% +$34.5K 0.02% 767
2021
Q1 		$830K Buy
55,267
+42,867
+346% +$694K 0.01% 958
2020
Q4 		$163K Buy
+12,400
New +$149K ﹤0.01% 1384
2020
Q3 		– Sell
-46,600
Closed -$533K – 1383
2020
Q2 		$533K Buy
+46,600
New +$528K 0.03% 602

Other funds holding VNDA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Susquehanna Fundamental Investments's VNDA Position: Q1 2026 in Review

Susquehanna Fundamental Investments sold out of Vanda Pharmaceuticals (VNDA) in Q1 2026, closing a stake of 15,137 shares — an estimated $134K sold.

Susquehanna Fundamental Investments first reported a position in VNDA in Q2 2020 and held it in 13 quarters. The position peaked at $1.63M in Q2 2024. 170 funds tracked by Wall St. Rank hold VNDA as of Q1 2026.

  • Susquehanna Fundamental Investments reported no remaining Vanda Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Susquehanna Fundamental Investments sold 15,137 Vanda Pharmaceuticals shares in Q1 2026, an estimated $134K.
  • Susquehanna Fundamental Investments first reported a position in Vanda Pharmaceuticals in Q2 2020 and held it in 13 quarters.
  • Susquehanna Fundamental Investments's Vanda Pharmaceuticals position peaked at $1.63M in Q2 2024.
  • 170 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q1 2026.

Based on Susquehanna Fundamental Investments's 13F filing for Q1 2026, filed 15 May 2026.